BriaCell Therapeutics Corp. (BCTX) Non Operating Investment Income (2025 - 2026)
BriaCell Therapeutics (BCTX) posted Non Operating Investment Income of $137830.0 for Q2 2026, up 54.02% sequentially from $89487.0 in Q4 2025.
BriaCell Therapeutics Corp. (BCTX) Non Operating Investment Income (2025 - 2026) Analysis & Trends
BriaCell Therapeutics has reported Non Operating Investment Income for 2 years, with the latest figure at $137830.0 in Q2 2026.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 137,830.00 |
| Apr 30, 2026 | 137,830.00 |
| Oct 31, 2025 | 89,487.00 |
| Oct 31, 2025 | 89,487.00 |